Arthroscopic partial meniscectomy in middle-aged patients with mild or no knee osteoarthritis:a protocol for a double-blind, randomized sham-controlled multi-centre trial by Hare, Kristoffer B et al.
Hare et al. BMC Musculoskeletal Disorders 2013, 14:71
http://www.biomedcentral.com/1471-2474/14/71STUDY PROTOCOL Open AccessArthroscopic partial meniscectomy in
middle-aged patients with mild or no knee
osteoarthritis: a protocol for a double-blind,
randomized sham-controlled multi-centre trial
Kristoffer B Hare1*, L Stefan Lohmander1,2,3, Robin Christensen1,4 and Ewa M Roos1Abstract
Background: Arthroscopic partial meniscectomy has been shown to be of no benefit to patients with concomitant
knee osteoarthritis, but the optimal treatment of a degenerative meniscus tear in patients with mild or no knee
osteoarthritis is unknown. This article describes the rationale and methodology of a randomized sham-controlled
trial to assess the benefit of arthroscopic partial meniscectomy of a medial meniscus tear in patients with mild or
no knee osteoarthritis. The objective of the study is to test whether the benefit from arthroscopic partial
meniscectomy in patients with knee pain, medial meniscus lesion and mild/no knee osteoarthritis, is greater after
arthroscopic partial meniscectomy than following sham surgery.
Methods: We will conduct a randomized controlled trial of treatment for degenerative meniscus tears in middle-aged
patients (aged 35–55 years) with an MRI-verified medial meniscus lesion and mild or no knee radiographic
osteoarthritis (grade 0–2 on the Kellgren & Lawrence scale). Patients will be randomized to receive either conventional
arthroscopic partial meniscectomy or a sham surgery procedure. The primary outcome will be the KOOS5 derived from
the ‘Knee Injury and Osteoarthritis Outcome Score’ at 2 years follow-up. Secondary outcomes at 2 years will include all
five individual subscales of the KOOS, a global perceived effect score, the Short-Form-36 health status score, EQ-5D for
economic appraisal and objective tests of muscle strength and physical function. Radiographic knee osteoarthritis will
be evaluated at 5 years.
Discussion: Demonstration of no additional benefit from arthroscopic partial meniscectomy on pain and function
should lead to a change in clinical care of patients with a degenerative meniscus tear. The results of this study will
provide empirical evidence for the potential benefit/harm of arthroscopic partial meniscectomy compared to a masked
sham-therapeutics intervention.
Trial registration: NCT01264991Background
A degenerative meniscus tear can be both a risk factor
for knee osteoarthritis (OA) and a sign of disease [1].
The current standard treatment for a degenerative me-
niscus tear is arthroscopic partial meniscectomy (APM),
the most commonly performed orthopedic procedure,
carried out on 1 million patients annually in the USA
[2]. Both meniscus injury and a meniscectomy are* Correspondence: kbhr@regionsjaelland.dk
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reproduction in any medium, provided the orassociated with the development of knee OA [3-5]. Pre-
vious studies have found APM to be no better than, or
have no additional benefit in comparison to, sham sur-
gery, lavage, optimized non-surgical treatment, or exer-
cise [6-8]. In all these studies, patients with knee OA
were included and the mean ages ranged from 52 to 62 -
years. The benefit in a younger population from an
APM procedure in a knee with a degenerative meniscus
tear and mild or no knee OA is, however, uncertain and
needs to be further investigated.
The benefits of the APM procedure on pain and func-
tion in patients with a degenerative meniscus tear, wered. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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1980s to the 1990s [9-11] when arthroscopic procedures
were gaining acceptance. However, poorly designed stud-
ies (retrospectively, use of non-validated outcome
measures, small patient populations, lack of control
groups and randomized allocation) have prevented firm
conclusions about the effect of the APM procedure. A
previous, but now withdrawn, Cochrane review from
2000 [12] concluded: ”. . .lack of randomized trials means
that no conclusions can be drawn on the issue of surgical
versus non-surgical treatment of meniscus injuries”. At
the time of this submission, there are, to our knowledge,
no published high quality controlled, randomized studies
that show a benefit from APM as compared to other
treatment modalities (placebo, physiotherapy, medica-
tion or exercise) on pain and function in patients aged
35–55 years with a degenerative medial meniscus tear.
Both meniscus injury and meniscectomy are
associated with a high risk of knee OA. Surgical resec-
tion of the meniscus leads to increased joint cartilage
contact stress through altered load transmission,
decreased shock absorption, and decreased joint stabil-
ity [13]. Of patients who undergo either total or partial
meniscectomy, 50% on average develop knee OA within
10–20 years [5]. In the elderly population in general,
and in patients with radiographic knee OA but no sur-
gery, there is a higher incidence of MRI-verified con-
comitant meniscus injury compared to controls [4]. It
remains unclear though, whether meniscectomy
increases the risk of knee OA per se, compared to non-
surgical treatment of a meniscus injury. In this study,
incidence or progression of radiographic OA will be
assessed at 5 years.
Methods
Study design
The study is designed as a prospective double-blind
randomized sham-controlled, multi-centre trial (RCT).
Patients will be randomly allocated to receive either an
APM or sham (i.e. placebo) procedure. The study is
designed according to current international standards
and will be reported using the recommendations in the
CONSORT statement [14]. The study is approved by the
Research Ethics Committee of Region Zealand, Denmark,
and is consistent with the Declaration of Helsinki.
Eligible patients will be screened using standardized
fixed flexion radiography of both knees, to assess the de-
gree of radiographic knee OA. If no, or at most mild,
knee OA on radiographs (Kellgren & Lawrence grades
0–2) is present, written information about the study and
a 10-minute information video will be given to the
patients to view at home. They will also be handed a
Patient-Reported Outcomes (PRO) questionnaire to fill
out at home to minimize bias. At the second contact, thepatients will receive an MRI scan of the affected knee and
perform tests of physical function. Thereafter, the relevant
researcher and the patient will be informed of the MRI
findings. If the MRI confirms a medial meniscus lesion,
the patient will be invited to participate in the study.
Patients not consenting to randomization will be followed
as an observational cohort with consecutive PRO evalu-
ation at the same time points as those included in the
RCT. However, the observational cohort will not be part
of the Intention-To-Treat (ITT) population.
At 3 months, patients will have a clinical examination,
fill out PRO questionnaires, and perform objective tests
of muscle strength and physical function. At 2 years,
follow-up will take place under the same conditions. At
5 years, all patients will have radiography of their knees
to assess possible onset or progress of knee OA from
baseline. The flowchart provides a visual description of
the study (Figure 1).Purpose and hypothesis
The purpose of the present study is to determine
whether the benefit from arthroscopic partial meniscec-
tomy in patients aged 35–55 years with knee pain and
an MRI-verified medial meniscus lesion, is greater after
arthroscopic partial meniscectomy than following sham
surgery. In addition, a 5-year follow-up of the same co-
hort will compare the effect of meniscectomy or sham
surgery on the incidence and progression of radiographic
knee OA.
We hypothesize that at 2 years, the change (improve-
ment) in KOOS5, a composite score derived from the
five subscales of the KOOS, is no greater after APM
than following sham surgery. Further, we hypothesize,
that at 5 years the rate of radiographic knee OA inci-
dence and progression is greater in the APM group than
in the sham surgery group.Participants
Eligibility criteria are patients between 35 and 55 years
of age with knee pain for more than 2 months without
significant trauma and an MRI-confirmed medial menis-
cus lesion. The patients must be eligible for outpatient
surgery. Patients will be excluded if they are in need of
acute surgery e.g. locking knees or high-energy trauma.
Patients with grade 3 or 4 knee OA on the Kellgren &
Lawrence classification [15,16] or knee surgery within
the previous 2 years will also be excluded. Patients must
be able to speak Danish and be free of any drug or alco-
hol abuse. Also, patients with trombophilia are excluded
so as to prevent a high risk of deep venous thrombosis.
The patients will be recruited through outpatient
departments of the orthopedic clinics in Region Zealand
on referral from general practitioners.
Figure 1 Study flowchart.
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Patients will be randomized to receive either arthro-
scopic partial meniscectomy (intervention A) or placebo
procedure/sham surgery (intervention B).
Intervention A
The arthroscopic partial meniscectomy will be performed
on an outpatient basis by experienced surgeons who are at
least in their final year of residency or are attending ortho-
pedic surgeons. We expect between 5–10 surgeons to be
involved in the study. All arthroscopies will be performedwith general anesthesia combined with local anesthesia
(Bupivacain combined with Adrenalin) 20 + 20 ml extra-
and intra-articularly, respectively. After general anesthesia
is induced, the knee will be examined for stability. There-
after, two standard portals on the lateral and medial sides
of the ligamentum patella will be created but no outflow
cannula inserted. An arthroscope will be used with a
pressure-controlled irrigation system. Tourniquet use will
be at the discretion of the surgeon. The strategy for the
meniscectomy will be to preserve as much tissue as pos-
sible. A standard operation protocol will be used to
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synovium and the medial and lateral menisci. The type, and
extent of meniscus lesion will be registered and changes in
the articular cartilage will be classified according to the
ICRS classification [17].
Intervention B
The sham procedure will be performed under the same
conditions as the arthroscopic surgery (Intervention A).
In summary, the patient will be fully sedated with gen-
eral anesthesia and the stability of the knee will be
examined. Local anesthetic will be applied and two skin
incisions will be made at the same locations and of the
same size as in Intervention A. Then the knee will be
manipulated as if a real arthroscopy was performed, the
spillage of water and all other equipment needed for an
arthroscopy will be used. A pre-recorded video of a
standard arthroscopic partial meniscectomy will be
played during the procedure. No instruments will enter
the arthroscopy portals to avoid the possibility of deep in-
fection, osteochondral lesions or unwanted interventions
by the surgeon.Postoperative regime (independent of concealed group
allocation)
All patients in both intervention groups will be given a
folder including an exercise program for postoperative
patients after knee arthroscopy. The folder gives a pres-
entation of seven different non-weight bearing exercises
(for the first week after surgery) and a further three
weight-bearing exercises thereafter. The exercises are for
the patients to carry out at home. The patients are also
recommended to start unloaded cycling, swimming or
walking after 1 week, and jogging or loaded cycling after
2–3 weeks.
Primary outcome
All outcomes are listed in Table 1. The primary outcome
at 2 years follow-up will be KOOS5, a composite score
derived from the Knee injury and Osteoarthritis Out-
come Score (KOOS) [18,19]. The KOOS is a self-
reported questionnaire comprising five subscales: pain,
other symptoms, activities in daily living (ADL), function
in sport and recreation and knee-related quality of life
(QOL). The previous week is taken into consideration
when patients are answering the questions. Standardized
answer options are given (5 boxes on a Likert scale) and
each question gets a score from 0 to 4. A normalized
score (100 indicating no symptoms and 0 indicating ex-
treme symptoms) is calculated for each subscale.
Subsequently, KOOS5 is calculated as a mean of the 5
subscale scores [KOOSpain + KOOSsymptoms + KOOSADL +
KOOSsport &rec + KOOSQOL]/5.Secondary outcomes
KOOS
All five subscales from the KOOS will be included indi-
vidually as secondary outcomes to support a clinically
valid interpretation of the result.
Global perceived effect
All patients are asked to answer on a seven-step global
rating scale (ranging from much worse, worse, slightly
worse, no difference, slightly better, better to much bet-
ter) the overall improvement in their knee symptoms
after the operation. This is implemented to determine
the minimal important change in the PROs. A clinically
important change is considered when the patient reports
an improvement or worsening of at least 2 steps from
‘no difference’, corresponding to ‘better’ or ‘worse’ on the
scale [20].Generic patient reported outcomes
Scores on the Medical Outcomes Study 36-item Short-
Form General Health Survey (SF-36) [21,22], which reflect
the health-related quality of life (SF-36 Health Survey) –
Acute version (1 week re-call period) will be used as a
generic measure of patient health status at 3 and 24 -
months. The SF-36 is comprised of 8 single subscale
scores associated with physical and mental health.
The Euroqol 5 Dimension (EQ-5D) health score will be
evaluated at baseline and at 3 and 24 months as a generic
measure for economic appraisal [23,24]. EQ-5D consists
of two pages - the EQ-5D descriptive system and the EQ
visual analogue scale (EQ VAS). The EQ-5D descriptive
system comprises the following 5 dimensions: mobility,
self-care, usual activities, pain/discomfort and anxiety/de-
pression. Each dimension has 3 levels: no problems, some
problems, severe problems.Performance measures
Tests of physical function will be performed at baseline
and after 3 and 24 months including a one-leg jump test,
maximum number of knee bends in 30 seconds and an
isometric knee extension strength measurement. The
patients will wear shorts, t-shirts, and sneakers. Tubigrip
stockings will cover both knees to disguise scars from
surgery; i.e., the test leaders will be masked regarding
injured knee. In order to avoid bias from the effect of
learning, randomization will be performed at each visit
to determine which leg is to be tested first.Single leg hop test
The one-leg hop will be included as a measure of phys-
ical function at a level above activities of daily living
[25]. The one leg hop requires leg muscle strength, knee
Table 1 Summary of measures to be collected
Variable Baseline Intermediate Primary endpoint Follow-up
T = 0 mths T = 3 mths T = 2 yrs T = 5 yrs
Baseline data
Age – yr @ n.a. n.a. n.a.
Female sex - no. (%) @ n.a. n.a. n.a.
Duration of knee symptoms - months @ n.a. n.a. n.a.
Height - cm @ n.a. n.a. n.a.
Body weight - kg @ n.a. @ @
Self-efficacy scale @ n.a. n.a. n.a.
Knee injury and Osteoarthritis Outcome Score (KOOS)
Pain – range: 0-100 @ @ @ @
Symptoms - range: 0-100 @ @ @ @
Function in daily living – range: 0-100 @ @ @ @
Function in sport and recreation – range: 0-100 @ @ @ @
Knee related Quality of life – range: 0-100 @ @ @ @
EQ-5D
Global disease descriptive system @ @ @ @
VAS patient global assessment of disease status - 0-100 @ @ @ @
Short-Form-36 health survey - acute form
Physical component summary – range: 0-100 @ @ @ @
Mental component summary – range: 0-100 @ @ @ @
Global Perceived Effect
7 step scale ranging from much worse to much better n.a. @ @ @
Standardized knee radiographic with SynaFlexer
JSW and presence of osteophytes @ n.a n.a @
Performance measures
Single leg hop test @ @ @ n.a.
Knee-bending test @ @ @ n.a.
Isometric knee extensor strength @ @ @ n.a.
@ = Assessed; n.a. = not assessed; VAS = Visual Analogue Scale; JSW = joint space width.
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will perform two practice trials and then three test trials
on each leg with hands behind their back. The best of
the three test trials will be used. An additional trial will
be performed if the patients improve more than 10
centimeters from trial two to trial three [27].
Knee-bend test
The maximum number of knee-bends performed in 30 -
seconds will be included as a measure of one-legged
physical function required in daily life. This test requires
fast changes between concentric and eccentric work and
resembles stepping down a stair and is valid and reliable
in meniscectomized patients [27].
Isometric knee extensor strength
Maximum knee-extension force will be measured using a
hand-held dynamometer (Powertrack Commander).Patients will sit at the end of the examination couch
with hip angle at 90° and knee angle at 60°. A large
Velcro strap will be attached to the examination couch
and the patient’s ankle will be perpendicular to the
lower leg. The transducer will be placed at the front of
the ankle under the Velcro strap to measure knee ex-
tension force. Patients will be instructed to contract “as
forcefully as possible” with a gradual increase in force
and strong verbal encouragement will be provided dur-
ing the contractions. They will perform 3 contractions
separated by a 60-second pause, and the highest value
will be used as the result.
The reliability of the isometric muscle tests with a
hand-held dynamometer has been reported to be satis-
factory [28-30]. The knee extension strength will be
expressed as maximal voluntary torque per kilo of body
mass using the external lever-arm length and body mass
of each patient.
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To evaluate progression of knee OA, a fixed-flexion radi-
ography procedure, with use of SynaFlexer [31], will be
performed at baseline and after 5 years. This provides
radiography at the exact same position and has been
validated in determining joint space width (JSW) in knee
osteoarthritis [32]. A single reader will score all the study
films from baseline and 5-year follow-up and will be
blinded to all clinical and questionnaire data and the base-
line x-ray result but not to the sequence of the x-rays. A
score will be assigned to each x-ray based on JSW and
presence of osteophytes using a standard atlas [33].
Exploratory outcomes
A questionnaire of patient self-efficacy modified from the
Danish Arthritis Self-Efficacy Scale to suit this somewhat
younger age group (not formally validated) and a question
on patient expectations will be included. Demographic
data will also be collected. Furthermore, participating
patients will be asked two questions regarding their study
participation. 1) “Which reason is the most motivating for
your participation?” and 2) “Which information was the
most useful when deciding?” Physical therapy prescribed
by either a general practitioner or a research staff member
will be carefully monitored with regard to the number of
exercise sessions.
Adverse events
Adverse events (not necessarily implying causality) will
be registered in both treatment arms. A priori defined
adverse events are: superficial infection, nerve or vessel
injury, deep infection, compartment syndrome, deep
venous thrombosis, myocardial infarction, stroke, and
death. Re-arthroscopy is also considered an adverse
event. Adverse events will be gathered from patients
themselves, from the patient record review, and from
the Danish National Patient Index (NPI) at the 3 and 24 -
months follow-ups.
Sample size
The sample-size calculation is based on the assumed su-
periority of the arthroscopic procedures over the sham
procedure. For a two-sample pooled t-test of a normal
mean difference with a two-sided significance level of 0.05,
assuming a common standard deviation (SD) of 15 in the
KOOS5 score, a sample size estimation of the ITT popula-
tion indicated that 36 individuals per group would be
required to obtain a power of at least 80% to detect a min-
imal important change (MIC) of 10 KOOS5 score units.
The MIC of 10 points and SD of 15 is based on findings
from similar patient groups and interventions [19].
Following these estimations, it was decided to include
80 individuals in total (40 patients in each group),
allowing for a 10% drop-out rate.Randomization
We will generate the two comparison groups using simple
randomization, with an equal allocation ratio (1:1), by refer-
ring to a computer-generated table of random numbers. To
ensure an equal distribution in the two groups, we will use
a block randomization, using blocks of 4 and 6. Participants
will be stratified for treatment centre. To ensure conceal-
ment of the assigned intervention, the surgeon will obtain a
sealed envelope containing the participant’s assigned inter-
vention after the patient is in the operating suite and has
been fully sedated. The consecutively numbered envelope
will be retrieved from a briefcase located at the actual oper-
ating theatre. The above mentioned allocation sequence
will be generated by an external co-investigator, the enrol-
ment will be performed by the first author and the assign-
ment will be at the operating room where the envelope will
be opened by the surgeon.
Blinding
The RCT will be a double-blind trial. All study personnel
and participants will be blinded to the intervention, except
for the surgeons and other operating theatre personnel,
who do not have any other role in the study.
Statistical methods
Treatment groups will be examined for comparability at
baseline with respect to demographic and prognostic
factors. An ITT analysis based on all the randomized
individuals - for the efficacy measures - will apply.
Comparisons between groups of the primary end point
will include all repeated measures and be analyzed with
the use of a mixed effects model, with random factors for
participant and centre.
Clinically important or relevant difference for the
KOOS5 and KOOS subscales were chosen as 10/100
points. Thus a confidence interval excluding differences
greater than 10 units between groups will be interpreted
as indicating the absence of a clinically meaningful dif-
ference. This means that, if the 95% Confidence Interval
around the group mean difference does not include a
potential clinical benefit of 10 KOOS points, then we
will then consider the therapeutic strategies equal.
Patients in the sham group who, later during the
course of the study, may have an APM procedure will,
according to the ITT principle, still be analyzed in the
group to which they were originally allocated. Secondar-
ily, all analyses will be supported/interpreted in the con-
text of the corresponding results according to the per
protocol populations.Treatment failure
No a priori criteria for cross-over are given. Should a pa-
tient contact the department because of unbearable
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had placebo surgery they will be offered a new arthros-
copy. These patients will be treated as cross-overs and
still be included in the study. In case of the patient hav-
ing had arthroscopic surgery in the first place the patient
will be referred to the responsible surgeon who will be
in charge of referring to further surgical or non-surgical
treatment and/or investigation. Both patient groups will
be asked to fill out a KOOS questionnaire at the extra
visit and will continue to be followed at the follow-ups
determined by the study protocol.”Discussion
Degenerative meniscus tears are common and related to
the development of knee osteoarthritis [1,3-5]. Arthro-
scopic partial meniscectomy is the current treatment of
choice in patients with mild or no concomitant knee
osteoarthritis but this has not been formally evaluated in
randomized placebo controlled trials.
The outcome of this study will show whether arthro-
scopic partial meniscectomy is a viable treatment modal-
ity. Inclusion of a sham surgery treatment will enable us
to study the effect of the partial meniscectomy per se.
The findings of this research will potentially be of inter-
national importance and will be readily translatable into
clinical practice, irrespective of the results. If our results
are in favor of APM, we will have evidence to support
continued use of APM in this patient category. If, on the
other hand, our results indicate that the efficacy of APM
is less than placebo (and it may do more harm), then
this would also significantly impact upon current prac-
tice and APM should not be the treatment of choice in
middle-aged patients with an MRI-verified meniscus tear
and mild or no knee osteoarthritis. No difference be-
tween APM and placebo might not be regarded as a
strong enough piece of evidence to stop operating on
middle-aged patients with meniscus tear and mild OA.
However, a finding of superiority for arthroscopy would
certainly increase the tendency to treat these patients
surgically, and a finding of superiority for placebo would
discourage operative treatment. Finding no effect of
APM would support the notion that a degenerative me-
niscus tear is the first sign of future knee OA. If so, the
treatment of choice should conform to treatment
guidelines for mild and moderate knee OA.
The study design has some limitations. The surgeon’s
level of experience may differ since we need to allow gen-
eral orthopedic surgeons to operate and not only sports
surgeons. However, this has the benefit of an increased
external validity. The population in the study is somewhat
heterogeneous, from patients with no osteoarthritis
to patients with mild osteoarthritis. We do not know
whether a meniscus tear has different etiology in thosewith and without radiographic OA and how this may
affect the result. There is no consensus on what defines a
symptomatic meniscus tear or whether or not to perform
an MRI before surgery. Clinical tests (McMurray, Apley,
etc.) have not been proven to diagnose a meniscus tear ac-
curately [34]. Therefore in this study, we included patients
with knee pain and an MRI-confirmed medial meniscus
lesion but there is a risk that, in some patients, symptoms
may actually not be caused by the meniscus tear. Further,
other patients who would otherwise have undergone a
knee arthroscopy may be excluded due to the MRI not
confirming a suspected meniscus tear. Another limitation
of using MRI as a diagnostic tool is the risk of a false posi-
tive result. If the patient will be randomized to a sham op-
eration, this error will never be discovered. We chose not
to perform a diagnostic arthroscopy in the sham group
primarily to reduce the risk of deep infection which we
find would be unacceptable for a sham intervention. Other
reasons were to avoid any accidental osteochondral lesions
from the arthroscope and unwanted intervention from the
surgeons.
The study does not include an activity score. A literature
search revealed a lack of valid self-reported instruments of
activity level for this diverse middle-aged population of
varying physical activity levels. Since providing patients
with accelerometers was not an option due to logistic
reasons, we have not included any measure of activity level
in this trial.
In spite of the above limitations, this study has strong
methodological rigor through its design as a double-
blinded placebo controlled RCT, compared to the earlier
non-controlled studies of degenerative medial meniscus
tears.
Ethical considerations are important when performing a
surgical placebo controlled study. One may ask, ‘Is it eth-
ical to perform placebo-controlled RCTs of surgery?’ since
the initial precept in medicine is “First, do no harm”. An
equally valid question though, may be, ‘Is it ethical not to
perform placebo-controlled RCTs within orthopedics [35]
and instead, potentially perform under-researched
operations which may not benefit the patient, or worse,
do harm?’
A recent study of vertebroplasty [36,37] has effectively
shown how a placebo-controlled surgical trial can evalu-
ate a given procedure that has been adopted widely
despite an absence of robust evidence. Currently, there
are three reasons to perform yet another placebo-
controlled arthroscopy study, in addition to the one
performed by Moseley and collaborators (2003). Firstly,
the current study will focus on younger patients; sec-
ondly, these patients are at an earlier stage of disease
and have not yet developed severe knee OA; and thirdly,
a replication study is required to make Moseley’s evi-
dence more convincing.
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